CEPTAVA

This brand name is authorized in Italy, Spain, UK.

Active ingredients

The drug CEPTAVA contains one active pharmaceutical ingredient (API):

1	Mycophenolic acid UNII WX877SQI1G - MYCOPHENOLATE SODIUM
	Mycophenolic acid is a potent, selective, uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase, and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. Mycophenolic acid has more potent cytostatic effects on lymphocytes than on other cells and is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.
	Read more about Mycophenolic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CEPTAVA Gastro-resistant tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AA06	Mycophenolic acid	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AA Selective immunosuppressants
Discover more medicines within L04AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	81580, 81581
GB	Medicines & Healthcare Products Regulatory Agency	348093, 348095
IT	Agenzia del Farmaco	044778037, 044778064